Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
Open Access
- 10 May 2004
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 34 (1), 77-84
- https://doi.org/10.1038/sj.bmt.1704531
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimenBlood, 2003
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based reviewTransplantation and Cellular Therapy, 2003
- Impact of complete remission with intensive therapy in patients with responsive multiple myelomaBone Marrow Transplantation, 2001
- Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centresBritish Journal of Haematology, 2001
- Donor leukocyte infusions for multiple myelomaBone Marrow Transplantation, 2000
- Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaBone Marrow Transplantation, 1999
- Graft-versus-myelomaBone Marrow Transplantation, 1998
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979